Breaking News
February 23, 2019 - FDA Adds Boxed Warning for Increased Risk of Death with Gout Medicine Uloric (febuxostat)
February 23, 2019 - Phone-based intervention aids rheumatoid arthritis care
February 23, 2019 - Opioid epidemic makes eastern inroads and targets African-Americans
February 23, 2019 - New identified biomarker predicts patients who might benefit from HER2-targeted agents
February 23, 2019 - Study offers new insights into mechanisms of changes in erythrocytes under stress
February 23, 2019 - Antipsychotic polypharmacy may be beneficial for schizophrenia patients
February 23, 2019 - Patients with diabetes mellitus have high risk of stable ischemic heart disease
February 23, 2019 - Transparency on healthcare prices played key role in Arizona health system’s turnaround
February 23, 2019 - A comprehensive, multinational review of peppers around the world
February 23, 2019 - Study finds modest decrease in burnout among physicians
February 23, 2019 - A simple change can drastically reduce unnecessary tests for urinary tract infections
February 23, 2019 - Deep Learning-Enhanced Device Detects Diabetic Retinopathy
February 23, 2019 - Researchers discover new binding partner for amyloid precursor protein
February 23, 2019 - Modest decrease seen in burnout among physicians, researchers say | News Center
February 23, 2019 - Transplanting bone marrow of young mice into old mice prevents cognitive decline
February 23, 2019 - Mogrify to accelerate novel IP and cell therapies using $3.7m USD funding
February 23, 2019 - Johns Hopkins study describes cells that may help speed bone repair
February 23, 2019 - Scientists demonstrate influence of food odors on proteostasis
February 23, 2019 - Researchers unlock the secret behind reproduction of fish called ‘Mary’
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Heart attacks more likely to be fatal in women and rates are rising
February 22, 2019 - Morning walks could be better than drugs at lowering blood pressure
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
Opioid Addicts Are Overdosing on Diarrhea Drug

Opioid Addicts Are Overdosing on Diarrhea Drug

image_pdfDownload PDFimage_print

THURSDAY, Feb. 7, 2019 — A popular anti-diarrheal drug is fast becoming another dangerous byproduct of the opioid crisis, as more addicts take huge quantities of it to ease withdrawal symptoms or get dangerously high.

Investigators found that the number of patients who were reported to the U.S. National Poison Data System after taking toxic doses of loperamide (one over-the-counter brand is Imodium) skyrocketed by more than 90 percent between 2010 and 2016.

Why the jump? The primary appeal of loperamide is that while it has an opioid-like effect on bowel movements and doesn’t produce a high in recommended doses, it can make someone high in huge quantities.

On top of that, it’s both cheap and accessible for addicts looking for ways to self-medicate the withdrawal symptoms that typically kick in when they try to stop taking powerful opioids.

“Loperamide is a safe, targeted and effective treatment for diarrhea and has been used since the 1970s, and is on the ‘World Health Organization List of Essential Medicines’ for [diarrhea],” explained study author Dr. Diane Calello. She is the executive and medical director of Rutgers University’s New Jersey Poison Control Center (NJPCC).

At recommended dosages, which the U.S. Food and Drug Administration pegs at 8 milligrams (mg) per day, loperamide does not produce euphoria or sedation, she said.

But “a ‘high’ can result when the drug crosses the blood-brain barrier at high doses, as seen in this study,” noted Calello. She and her colleagues found that majority of loperamide abuse cases involve extremely high doses, in the range of between 50 and 100 2-mg pills.

Emily Einstein is deputy chief of the science policy branch at the U.S. National Institute on Drug Abuse. She stressed that “the appeal of loperamide is likely due to its easy availability, not due to the quality of the high. It appears that many of those who misuse loperamide are not seeking a high at all, but are rather doing so to self-treat opioid withdrawal.

“It is not surprising that people with opioid addiction seek out and share methods of staving off opioid withdrawal, especially in the context of the current opioid crisis,” Einstein explained.

“While effective medications exist for the treatment of opioid addiction — namely buprenorphine, methadone and extended-release naltrexone and the opioid withdrawal drug [lofexidine], they are seriously underused,” she said.

Instead, the Rutgers study showed that since 2010 there has been a steady annual rise in the number of loperamide abuse cases being reported to a national overdose registry. The average age was 27, most were white, and more than half were male.

At the national level, there were 916 overdoses in 2015, resulting in two deaths. And that, said Einstein, suggests the loperamide threat needs to be seen in context, since “its relative toxicity is nowhere near that of other opioids, especially illicit synthetics such as fentanyl, a drug category that killed more than 28,000 people in 2017.”

Still, the question remains: what can be done?

One option, making loperamide prescription-only, is less than ideal, cautioned Calello, “because there are many people who use the medication appropriately, for whom needing a prescription would limit access.

“Education about the risks of excessive loperamide dosing is key,” she said. “Opioid users who take it in high doses may assume that its toxicity is typical of opioids — take a little too much, get sleepy, take a lot too much, stop breathing.

“While this “typical” toxicity is reversed by naloxone, loperamide causes cardiac arrhythmias and cardiac arrest — for which naloxone does nothing,” Calello warned.

On that front, the FDA issued a high-dose cardiac risk safety warning in 2016. “So, getting the word out that this is a uniquely dangerous opioid medication in high doses is important,” Calello said.

Linda Richter, director of policy research and analysis with the Center on Addiction in New York City, thinks that loperamide abuse is just the latest sign that our health care system fails at solving the addiction problem.

“Unless we make it easier for people with opioid addiction to get the treatment they need, they will do whatever it takes to try to manage their addiction symptoms on their own,” she said, “whether it is by using potentially deadly drugs like fentanyl or by turning to high doses of legal drugs like loperamide to stave off their excruciating withdrawal symptoms and cravings.”

The findings are published in the Feb. 4 issue of the journal Clinical Toxicology.

More information

The U.S. Food and Drug Administration has more information on loperamide misuse and safety.

© 2019 HealthDay. All rights reserved.

Posted: February 2019

Tagged with:

About author

Related Articles